MX9305010A - Oligomeros antiangiogenicos. - Google Patents

Oligomeros antiangiogenicos.

Info

Publication number
MX9305010A
MX9305010A MX9305010A MX9305010A MX9305010A MX 9305010 A MX9305010 A MX 9305010A MX 9305010 A MX9305010 A MX 9305010A MX 9305010 A MX9305010 A MX 9305010A MX 9305010 A MX9305010 A MX 9305010A
Authority
MX
Mexico
Prior art keywords
oligomers
angiogenic
backbone
polyurs
metastases
Prior art date
Application number
MX9305010A
Other languages
English (en)
Inventor
Paul S Wright
Alan J Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9305010A publication Critical patent/MX9305010A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

Los oligómeros de la presente invención son poliurias, policarbonatos, poliésteres o poliamidas que tienen un número promedio de peso molecular de 10,000. Estos oligómeros son solubles en agua, que tienen un esqueleto o estructura principal rígida con un anión de separación predecible y son farmacéuticamente aceptables. Los oligómeros son útiles para inhibir la angiogénesis y pueden utilizarse en el tratamiento de tumores y metástasis.
MX9305010A 1992-08-19 1993-08-18 Oligomeros antiangiogenicos. MX9305010A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93211192A 1992-08-19 1992-08-19

Publications (1)

Publication Number Publication Date
MX9305010A true MX9305010A (es) 1994-03-31

Family

ID=25461789

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305010A MX9305010A (es) 1992-08-19 1993-08-18 Oligomeros antiangiogenicos.

Country Status (12)

Country Link
US (1) US5593664A (es)
EP (1) EP0655923A1 (es)
JP (1) JPH08500590A (es)
AU (1) AU675961B2 (es)
CA (1) CA2142110A1 (es)
HU (1) HUT72993A (es)
IL (1) IL106707A (es)
MX (1) MX9305010A (es)
NO (1) NO950602L (es)
NZ (1) NZ254646A (es)
WO (1) WO1994004165A1 (es)
ZA (1) ZA935941B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0749690A1 (en) 1995-06-22 1996-12-27 Unilever N.V. Heat-settable, frozen bakery dough systems
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US20040022788A1 (en) * 1998-05-19 2004-02-05 Moser Tammy L. Compositions and methods for promoting or inhibiting angiogenesis
EP2311490A3 (en) 1998-07-13 2011-05-04 Board of Regents, The University of Texas System Uses of antibodies to aminophospholipids for cancer treatment
SI1107795T1 (en) 1998-09-04 2003-06-30 The Regents Of The University Of Michigan Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
GB0001481D0 (en) * 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
EP2283869A3 (en) 2002-07-15 2012-06-27 Board of Regents, The University of Texas System Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer
WO2005025515A2 (en) * 2003-09-12 2005-03-24 California Institute Of Technology Proteasome pathway inhibitors and related methods
ME01881B (me) 2004-01-22 2014-12-20 Univ Miami Topijske formulacije koenzima q10 i postupci upotrebe
MX2010005104A (es) 2007-11-09 2010-08-04 Peregrine Pharmaceuticals Inc Composiciones de anticuerpo anti-factor de crecimiento endotelial vascular y metodos.
CA2737146A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
CN102382300B (zh) * 2011-10-11 2013-05-08 上海交通大学 一种水溶性磺化聚酰胺及其制备方法
EP3576726A1 (en) 2017-02-06 2019-12-11 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US4027038A (en) * 1976-05-10 1977-05-31 American Cyanamid Company Complement inhibitors
US4087548A (en) * 1976-05-10 1978-05-02 American Cyanamid Company Complement inhibitors
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
JPH0140026B2 (es) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4724235A (en) * 1981-05-20 1988-02-09 A. H. Robins Company, Incorporated N-(arylthioalkyl)-N'-(aminoalkyl)ureas useful in the treatment of arrhythmia
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US5019556A (en) * 1987-04-14 1991-05-28 President And Fellows Of Harvard College Inhibitors of angiogenin
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process

Also Published As

Publication number Publication date
ZA935941B (en) 1994-03-10
IL106707A (en) 1997-02-18
EP0655923A1 (en) 1995-06-07
JPH08500590A (ja) 1996-01-23
CA2142110A1 (en) 1994-03-03
NO950602D0 (no) 1995-02-17
NO950602L (no) 1995-02-17
HUT72993A (en) 1996-06-28
WO1994004165A1 (en) 1994-03-03
IL106707A0 (en) 1993-12-08
US5593664A (en) 1997-01-14
HU9500493D0 (en) 1995-04-28
AU675961B2 (en) 1997-02-27
NZ254646A (en) 1997-06-24
AU4684893A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
ES2116295T3 (es) Oligomeros de virus anti-herpes y citomegalovirus.
MX9305010A (es) Oligomeros antiangiogenicos.
ES2061998T3 (es) Resinas de refuerzo provisional en estado humedo con grupos funcionales nitrogenados, heterociclicos, no nucleofilos y productos de papel que las contienen.
DE69212210D1 (de) Sicherheitstrokar
DE69229558T2 (de) Vor oxydation geschützte arylcyclobutanpolymere
BR9204772A (pt) Trava para fio de linha
ES2099962T3 (es) Oligomeros que inhiben la proliferacion.
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
DE59203558D1 (de) Schleifmittel.
DE69702498D1 (de) Vergrösserung des molekulargewichts von polykondensaten
ES2071481T3 (es) Prevencion de adherencias sinoviales.
ES2016781A4 (es) Procedimiento para regulacion del cloro libre residual en el agua.
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE312479T1 (de) Gegen faelschung geschuetzte bankausweiskarte.
DE69204851D1 (de) Sicherheitskarte.
DE69202489D1 (de) Sicherheitsverschluss.
DE69209529T2 (de) Aromatische Polyamid-Oligomere
IT220307Z2 (it) Dispositivo antifurto per la protezione e la delimitazione di spazi.
ES1017034Y (es) Sistema detector de forzamiento o de rotura alambrica para vallas de seguridad.
IT218119Z2 (it) Gradino antisdrucciolo e antiinfortunistico per scala di piscina.
ES1012600Y (es) Dispositivo protector para candados antirrobo.
ITTO910476A0 (it) Barriera di protezione per macchine potenzialmente pericolose
BR7101142U (pt) Cofre com segredo
IT8964206V0 (it) Segnalatore o visivo o audio/visivo del sistema di protezione adottato per la salvaguardia del bene.
ES1026357Y (es) Aparato para el tratamiento electrostatico del agua.